Bilal Muhsin Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months, 1 week ago
Bilal Muhsin has an estimated net worth of at least $10.1 million*, as of Oct. 29, 2025. They own 24,172 shares of MASI stock. They have sold 40,000 shares of MASI stock since 2021, for an estimated $6.7 million.
Bilal Muhsin $MASI SEC Form 4 Insider Trading
Bilal Muhsin has filed a total of 11 insider trades in $MASI since 2021. Their most recent trade was a sale of 3,881 shares, made on May 12, 2025. Their largest trade was a sale of 10,087 shares, made on Mar 10, 2025. We estimate that they now own 24,172 shares of $MASI, worth an estimated $3.5 million.
Insider Trading at $MASI
There have been a total of 52 insider trades reported at $MASI since 2021, with 56,383 shares purchased and 308,633 shares sold. The most active insider traders in $MASI stock have been Joe E Kiani, Bilal Muhsin, and Anand Sampath. The most recent trade was a sale of 6,560 shares reported by Anand Sampath (EVP, Ops & Clinical Research), made on Jan 28, 2026.
History of Insider Stock Trades by Bilal Muhsin
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MASI
|
Sale | 3,881 | May 12, 2025 | May 14, 2025, 5:32 p.m. |
|
MASI
|
Sale | 5,594 | May 12, 2025 | May 14, 2025, 5:32 p.m. |
|
MASI
|
Sale | 525 | May 12, 2025 | May 14, 2025, 5:32 p.m. |
|
MASI
|
Sale | 1,436 | Mar 10, 2025 | March 12, 2025, 8:05 p.m. |
|
MASI
|
Sale | 1,700 | Mar 10, 2025 | March 12, 2025, 8:05 p.m. |
|
MASI
|
Sale | 2,400 | Mar 10, 2025 | March 12, 2025, 8:05 p.m. |
|
MASI
|
Sale | 6,965 | Mar 10, 2025 | March 12, 2025, 8:05 p.m. |
|
MASI
|
Sale | 1,716 | Mar 10, 2025 | March 12, 2025, 8:05 p.m. |
|
MASI
|
Sale | 1,761 | Mar 10, 2025 | March 12, 2025, 8:05 p.m. |
|
MASI
|
Sale | 3,935 | Mar 10, 2025 | March 12, 2025, 8:05 p.m. |
|
MASI
|
Sale | 10,087 | Mar 10, 2025 | March 12, 2025, 8:05 p.m. |
$MASI Executives and Stock Owners with Insider Trades
-
Joe E Kiani, CEO and Chairman of the Board
-
Bilal Muhsin, Chief Operating Officer
-
Anand Sampath, EVP, Ops & Clinical Research
-
Micah W Young, EVP & Chief Financial Officer
-
Tao Levy, EVP, Bus Dev
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.